Rheumatoid arthritis: is it a coronary heart disease equivalent?
Current Opinion in CardiologyPublished 15 April 2011
Holly John, Tracey E. Toms, George D. Kitas
Citations36
SJR quartileQ2
SJR score0.90
SNIP0.74
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Management of RA-related CVD is likely to require both aggressive control of inflammation and systematic screening and management of classical CVD risk factors, and it remains unknown whether primary prevention strategies applied successfully in DM2 would be equally easy to implement and demonstrate similar benefits in people with RA.
Abstract
Management of RA-related CVD is likely to require both aggressive control of inflammation and systematic screening and management of classical CVD risk factors. It remains unknown whether primary prevention strategies applied successfully in DM2 would be equally easy to implement and demonstrate similar benefits in people with RA.
Keywords
Medicine
New England Journal of MedicineAtherosclerosis — An Inflammatory Disease
21,594 Citations1999Russell Ross
BMJPredicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
1,492 Citations2008Julia Hippisley–Cox, Carol Coupland +5 more
Arthritis Care & ResearchRisk of cardiovascular mortality in patients with rheumatoid arthritis: A meta‐analysis of observational studies
1,459 Citations2008J. Antonio Aviña‐Zubieta, Hyon K. Choi +4 more
Annals of the Rheumatic DiseasesEULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
1,294 Citations2009M.J. Peters, Deborah Symmons +16 more
Ten recommendations were made for CV risk management in patients with rheumatoid arthritis, and the strength of the recommendations differed between RA on the one hand, and AS and PsA, on the other, as evidence for an increased CV risk is most compelling for RA.
The LancetTrial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial
822 Citations2004David McCarey, Iain B. McInnes +6 more
These data show that statins can mediate modest but clinically apparent anti-inflammatory effects with modification of vascular risk factors in the context of high-grade autoimmune inflammation.
The Open Cardiovascular Medicine JournalThe Endothelium and Its Role in Regulating Vascular Tone
796 Citations2010Aamer Sandoo, Jet Veldhuijzen Zanten +3 more
The present review aims to provide an insight into the anatomy of the vasculature as well as the underlying endothelial cell physiology to assess vascular function and structure in different clinical populations.
Canadian Journal of Cardiology2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations
771 Citations2009Jacques Genest, Ruth McPherson +21 more
Arthritis & RheumatismReduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics Register
561 Citations2007William G Dixon, Kath Watson +4 more
The hypothesis that the powerful antiinflammatory effect of anti–tumor necrosis α (anti-TNFα) therapy might lead to a reduction in the incidence of myocardial infarction (MI) in patients with RA is tested, and it is indicated that RA patients treated with anti-T NFα do not have a lower incidence of MI compared with RA patients treating with traditional DMARDs.
CirculationRheumatoid Arthritis Is Associated With Increased Aortic Pulse-Wave Velocity, Which Is Reduced by Anti–Tumor Necrosis Factor-α Therapy
412 Citations2006Kaisa Mäki-Petäjä, Frances Hall +9 more
RA is associated with increased aortic stiffness, which correlates with current but not historical measures of inflammation, suggesting that increased aortsic stiffness may be reversible and effective control of inflammation may be of benefit in reducing cardiovascular risk in patients with RA.
Journal of Internal MedicineC‐reactive protein and coronary heart disease: a critical review
368 Citations2008Juan P. Casas, Tina Shah +3 more
The evidence is critically reviewed and the potential pathogenicity of high acute phase circulating CRP concentrations in individuals with substantial tissue damage and modest but persistent increases in baseline values in generally healthy subjects is distinguished.
Arthritis Care & ResearchDoes rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study
367 Citations2009Mike J. Peters, Vokko P. van Halm +11 more
The risk of CVD in RA was significantly elevated compared with the general population, and comparable with the magnitude of risk in type 2 DM.
Annals of the Rheumatic DiseasesRheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRÉ Investigation
356 Citations2008Vokko P. van Halm, Matthew Peters +13 more
The prevalence of CVD in RA is increased to an extent that is at least comparable to that of DM2, a well-established cardiovascular risk factor, which should have implications for primary cardiovascular prevention strategies in RA.
Annals of the Rheumatic DiseasesTumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis
348 Citations2010Jeffrey D. Greenberg, Joel M. Kremer +8 more
Patients using a TNF antagonist experienced a reduced risk of the primary composite cardiovascular endpoint and the risk reduction associated with TNF antagonists was also observed for non-fatal cardiovascular events.
Postgraduate Medical JournalPrevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors
347 Citations2006Christina Daousi, I. F. Casson +4 more
Obese patients with type 2 diabetes were younger, had poorer glycaemic control, higher blood pressures, worse lipid profiles, and were more likely to be receiving antihypertensive and lipid lowering drugs compared with patients with BMI <30 kg/m2.
Annals of the Rheumatic DiseasesDo cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
316 Citations2007Á. Sánchez-González, Hilal Maradit Kremers +6 more
Differences in the overall impact of traditionalCV risk factors suggest that strategies to prevent CV disease and mortality focused solely on controlling traditional CV risk factors may be relatively less beneficial in RA subjects than in the general population.
Annals of the Rheumatic DiseasesCardiovascular disease in rheumatoid arthritis: state of the art and future perspectives
310 Citations2010George D. Kitas, Sherif E. Gabriel
More research is necessary to uncover the exact mechanisms responsible for this phenomenon, develop accurate systems used to identify patients at high risk, design and assess prevention strategies specific to this population of patients.
Lara D. VeekenPrevalence and associations of hypertension and its control in patients with rheumatoid arthritis
298 Citations2007Vasileios F. Panoulas, Karen Douglas +8 more
HT is highly prevalent in RA, under-diagnosed particularly in the young, and under-treated particularly in old RA patients with CVD, and those with any cardiovascular comorbidity may require particularly aggressive monitoring and treatment strategies.
Lara D. VeekenHypertension in rheumatoid arthritis
297 Citations2008Vasileios Panoulas, Giorgos S. Metsios +5 more
The mechanisms that may lead to increased blood pressure in patients with RA are discussed, paying particular attention to commonly used drugs for the treatment of RA, and screening strategies and management algorithms for HT are suggested.
Annals of the Rheumatic DiseasesExplaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity
288 Citations2010Daniel H. Solomon, Joel M. Kremer +7 more
Traditional CV risk factors and markers of RA severity both contribute to models predicting CV events, and increasing numbers of both types of factors are associated with greater risk.
Lara D. VeekenRheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review
234 Citations2007George S. Metsios, Antonios Stavropoulos‐Kalinoglou +6 more
There is strong evidence suggesting that exercise from low to high intensity of various modes is effective in improving disease-related characteristics and functional ability in RA patients.
Annals of the Rheumatic DiseasesInfluence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis
223 Citations2004Călin D. Popa, M G Netea +5 more
TNF neutralisation with monoclonal anti-TNF antibodies increased HDL-cholesterol levels and decreased CRP and IL6 levels after 2 weeks, suggesting this treatment may improve the cardiovascular risk profile of patients with RA.
Lara D. VeekenTumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
216 Citations2010Sarah Westlake, Alexandra N. Colebatch +7 more
In many studies, TNF antagonists appear to reduce the likelihood of CVD in individuals with RA, and there does not appear to be an increased risk of cardiac failure.
Arthritis & RheumatismInsulin resistance and impaired beta cell function in rheumatoid arthritis
214 Citations2006Patrick H Dessein, Barry I. Joffe
The modifiable factors of abdominal obesity, antihypertensive therapy, disease activity, and use of glucocorticoids appear to affect glucose metabolism in RA.
Annals of the Rheumatic DiseasesRisk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis
213 Citations2010Daniel H. Solomon, Þorvarður Jón Löve +2 more
RA and PsA/PsO appear to be associated with an increased risk of diabetes mellitus, and the ability of potent antirheumatic treatments to reverse this trend warrants study.
Lara D. VeekenObesity in rheumatoid arthritis
209 Citations2010Antonios Stavropoulos‐Kalinoglou, Giorgos S. Metsios +2 more
This review summarizes the studies that have looked into obesity in the RA population, evaluate their findings, identify knowledge gaps and propose directions for future research on BMI.
Lara D. VeekenSystemic inflammation as a risk factor for atherothrombosis
177 Citations2007Sander I. van Leuven, Remco Franssen +4 more
Several chronic inflammatory disorders, such as systemic lupus erythematosus and rheumatoid arthritis, and chronic infections that are associated with a chronic inflammatory state, including human immunodeficiency virus (HIV) infection, areassociated with an increased incidence of cardiovascular disease (CVD).
Arteriosclerosis Thrombosis and Vascular BiologyAtherosclerosis in Rheumatoid Arthritis Versus Diabetes
175 Citations2009Kimon Stamatelopoulos, George D. Kitas +10 more
Preclinical atherosclerosis appears to be of equal frequency and severity in rheumatoid arthritis and diabetes of similar duration with differential impact of traditional risk factors and systemic inflammation.
Arthritis & RheumatismAbdominal adiposity in rheumatoid arthritis: Association with cardiometabolic risk factors and disease characteristics
170 Citations2010Jon T. Giles, Matthew Allison +7 more
The distribution of abdominal fat differs significantly by RA status, and the more potent association of VFA with cardiometabolic risk factors in men and women with RA, may contribute to cardiovascular risk in RA populations.
The Journal of RheumatologyAutoantibodies and the Risk of Cardiovascular Events
162 Citations2009Kimberly P. Liang, Hilal Maradit Kremers +5 more
RF and ANA positivity are significant predictors of CV events and mortality in both those with and those without rheumatic diseases, and these results support the role of immune dysregulation in the etiology of CV disease.
Nature Reviews RheumatologyRheumatoid cachexia and cardiovascular disease
158 Citations2010Gregory D. Summers, Giorgos S. Metsios +2 more
Rheumatoid cachexia might represent the 'worst of both worlds' with respect to cardiovascular outcome, but until diagnostic criteria for this condition are agreed upon, its effect on cardiovascular disease risk remains controversial.
Lara D. VeekenBlockade of tumour necrosis factor- in rheumatoid arthritis: effects on components of rheumatoid cachexia
144 Citations2007Giorgos S. Metsios, Antonios Stavropoulos‐Kalinoglou +6 more
Seminars in Arthritis and RheumatismCarotid Intima Media Thickness in Rheumatoid Arthritis as Compared to Control Subjects: A Meta-Analysis
141 Citations2010Alper M. van Sijl, Mike J. Peters +6 more
The observations support the current evidence base for an increased cardiovascular burden in RA and support the use of cIMT in observational studies in RA patients and determine its utility as a surrogate cardiovascular risk marker in RA in prospective studies.
Autoimmunity ReviewsCardiovascular risk in rheumatoid arthritis
138 Citations2009Michael T. Nurmohamed
There is accumulating evidence that the increased cardiovascular risk in rheumatoid arthritis is comparable to that of type 2 diabetes and actually RA should be seen as a new, independent, cardiovascular risk factor for which cardiovascular risk management is essential.
Arthritis Research & TherapyCoronary arterial calcification in rheumatoid arthritis: comparison with the Multi-Ethnic Study of Atherosclerosis
136 Citations2009Jon T. Giles, Moysés Szklo +9 more
Increasing rheumatoid arthritis disease severity was associated with a higher prevalence and greater extent of coronary artery calcification, potentially mediated through an atherogenic effect of chronic systemic inflammation.
Annals of the Rheumatic DiseasesStatin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?
132 Citations2009Tracey E. Toms, V. F. Panoulas +8 more
Depending on the risk stratification method, 2% to 26% of patients with rheumatoid arthritis without CVD have sufficiently high risk to require statin therapy, yet most of them remain untreated.
CirculationDeclines in Mortality From Acute Myocardial Infarction in Successive Incidence and Birth Cohorts of Patients With Rheumatoid Arthritis
120 Citations2004Eswar Krishnan, Vijaya Bharathi Lingala +1 more
Current Vascular PharmacologyDyslipidaemia in Rheumatoid Arthritis: The Role of Inflammation, Drugs, Lifestyle and Genetic Factors
118 Citations2010Tracey E. Toms, Deborah Symmons +1 more
This review discusses lipid abnormalities specifically in the context of RA and highlights the potential impact of inflammation, genetic factors, lifestyle, and anti-rheumatic drugs on lipid metabolism.
Current Vascular PharmacologyThe Rationale for Comparative Studies of Accelerated Atherosclerosis in Rheumatic Diseases
98 Citations2010Armen Yuri Gasparyan, Antonios Stavropoulos‐Kalinoglou +4 more
Evidence suggests that enhanced atherosclerosis causes premature cardiovascular events in the autoimmune disease, SLE, and the "high-grade" inflammatory rheumatic disease, RA and in the setting of BD, and preliminary data suggest thatEnhanced atherogenesis may accompany FMF in the absence of sufficient suppression of inflammation by colchicine.
Annals of the Rheumatic DiseasesHeart disease and rheumatoid arthritis: understanding the risks
85 Citations2009S. E. Gabriel
RA-specific cardiovascular risk prediction tools are needed, as well as clinical trials to assess the impact of therapies and tight control of inflammation in RA patients on cardiovascular outcomes and mortality.
Lara D. VeekenAssociation of serum uric acid with cardiovascular disease in rheumatoid arthritis
82 Citations2007Vasileios F. Panoulas, Haralampos J. Milionis +6 more
This cross-sectional study suggests that SUA may be independently associated with CVD in RA patients, and needs to be confirmed in prospective studies.
Annals of the Rheumatic DiseasesAssociations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis
76 Citations2008Antonios Stavropoulos‐Kalinoglou, George S. Metsios +7 more
RA-specific BMI cut-off points better identify patients with RA at increased CVD risk and weight-loss regimens should be developed and applied in order to reduce CVD in patients withRA.
BMJRecent advances in the management of rheumatoid arthritis
73 Citations2010Naomi B. Klarenbeek, P. J. S. M. Kerstens +3 more
Evidence from randomised trials, systematic reviews, and recently published guidelines is reviewed and the new approach to treatment is outlined, emphasising the importance of early diagnosis, referral, and treatment.
Best Practice & Research Clinical RheumatologyCardiovascular co-morbidity in early rheumatoid arthritis
73 Citations2009Holly John, George D. Kitas +2 more
The evidence for co-morbid CVD complicating early RA is discussed, including examining studies of mortality outcome and CVD events in cohorts of early RA patients as well as studies using surrogate markers for atherosclerotic CVD in RA.
AngiologyAre Lipid Ratios Less Susceptible to Change With Systemic Inflammation Than Individual Lipid Components in Patients With Rheumatoid Arthritis?
67 Citations2010Tracey E. Toms, Vasileios F. Panoulas +7 more
The effects of inflammation on individual lipid levels may underestimate lipid-associated cardiovascular disease (CVD) risk in RA, thus lipid ratios may be more appropriate for CVD risk stratification in RA.
Kidney InternationalNeed for better diabetes treatment for improved renal outcome
57 Citations2011Peter Rossing, Dick de Zeeuw
Improved management of diabetes is clearly required, including improved glycemic control to avoid initiation of diabetic nephropathy, particularly in high-risk patients, and new treatment strategies with fewer side effects are necessary.
International Journal of Clinical PracticeThe interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better
55 Citations2010Matthew Peters, Alexandre E. Voskuyl +4 more
There is abundant evidence that patients with rheumatoid arthritis (RA) are at elevated cardiovascular risk and the contribution of lipids in general is well recognised, but is as yet unclear in inflammatory diseases such as RA.
Annals of the Rheumatic DiseasesCardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis
50 Citations2009Dimitrios Daoussis, V. F. Panoulas +7 more
Renal dysfunction in RA is quite common and associates with classic cardiovascular risk factors such as advanced age and dyslipidaemia, levels of SUA and the presence of extra-articular disease.
PubMedIndependent role of conventional cardiovascular risk factors as predictors of C-reactive protein concentrations in rheumatoid arthritis.
45 Citations2007Patrick H Dessein, Gavin R. Norton +3 more
In patients with RA with NCEP-defined central obesity, insulin resistance explains a degree of the variability of CRP concentrations equivalent to that of disease activity.
Journal of Human HypertensionSerum uric acid is independently associated with hypertension in patients with rheumatoid arthritis
39 Citations2007Vasileios F. Panoulas, Karen Douglas +8 more
It is suggested that SUA levels are independently associated with HT in RA patients, and prospective longitudinal studies are needed to confirm and further explore the causes and implications of this association.
QJMThe treatment of coronary artery disease in patients with chronic kidney disease
37 Citations2006Nicola C. Edwards, Richard P. Steeds +2 more
It is not clear which revascularization technique has a better outcome in patients 'equally suitable' on angiographic criteria for either procedure, and the high rate of late adverse cardiovascular events after both CABG and angioplasty accentuates the need for effective secondary preventive therapy disease in high-risk patients.
Annals of the Rheumatic DiseasesDyslipidaemia, statins and rheumatoid arthritis
34 Citations2009Michael T. Nurmohamed, Ben A. C. Dijkmans
The lipid profile over time and its relationship with inflammation and serological markers, in subjects who later developed RA was investigated, in the light of results from other studies.
Arthritis Research & TherapyUric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis
31 Citations2009Dimitrios Daoussis, Vasileios F. Panoulas +7 more
UA is a strong correlate of renal dysfunction in RA patients, and RA patients with elevated UA may require screening for renal dysfunction and appropriate management.
Musculoskeletal Care‘All singing from the same hymn sheet’: Healthcare professionals' perceptions of developing patient education material about the cardiovascular aspects of rheumatoid arthritis
16 Citations2009Holly John, Elizabeth Hale +3 more
Assessment of healthcare professionals' perceptions of rheumatoid arthritis can inform the development of novel education material to fulfil a currently unmet clinical need.